Actively Recruiting

Phase Not Applicable
Age: 18Years - 50Years
FEMALE
NCT06615232

The Impact of Vaginal Washing on Cervical Inflammation

Led by University of Washington · Updated on 2026-05-05

122

Participants Needed

1

Research Sites

211 weeks

Total Duration

On this page

Sponsors

U

University of Washington

Lead Sponsor

N

National Institutes of Health (NIH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Vaginal washing is a common practice that many women perceive as hygienic. However, vaginal washing has been linked to adverse reproductive health outcomes including increased HIV acquisition risk. The mechanism linking vaginal washing to HIV risk remains unknown, but may be related to increased inflammation caused by intravaginal washing practices. The primary objective of this study is to test the hypothesis that a vaginal washing cessation intervention will reduce concentrations of soluble inflammatory mediators in cervicovaginal fluid and total immune cells in mucosal tissue, reduce cervical epithelial disruption, and increase concentrations of protective vaginal Lactobacillus spp. compared to control.

CONDITIONS

Official Title

The Impact of Vaginal Washing on Cervical Inflammation

Who Can Participate

Age: 18Years - 50Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Reports vaginal washing beyond the introitus in the past week
  • Female, aged 18-50
  • Presence of a cervix
  • Informed consent obtained and form signed
  • HIV-seronegative
  • Non-pregnant (urine b2-hCG negative)
  • Willing to abstain from sex for 14 days after biopsy
  • Post-menarche and pre-menopause
Not Eligible

You will not qualify if you...

  • Less than 3 months postpartum or currently breastfeeding
  • Current menstruation (can enroll after menses)
  • History of bleeding disorder
  • Visible cervical abnormality requiring evaluation
  • Medical contraindication to study protocol
  • Visible cervicovaginal ulcers or lesions
  • Positive test for gonorrhea, chlamydia, trichomonas, or vulvovaginal candidiasis

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Pwani Research Center

Mombasa, Kenya

Actively Recruiting

Loading map...

Research Team

M

Michelle Sabo, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here